Skip to content
Luna Metabolic
Menu

We earn commissions; partners may appear first. Disclosure

FORM (by GBY) logo

FORM (by GBY) review

By Luna Editorial TeamUpdated

Standard GLP-1, combined FORM3 and oral offers with more visible current prices, but overlapping product and bundle presentations.

What FORM (by GBY) costs

Semaglutide
$159/mo ongoing standard injection ($99 first month); FORM3 blend $199/mo ongoing ($129 first month)
Tirzepatide
$219/mo ongoing standard injection ($169 first month); FORM3 blend $299/mo ongoing ($199 first month)
Where it treats
Current medication-specific state availability requires confirmation
Brand-name GLP-1s
Yes

How FORM (by GBY) scores for women

Six women's-health factors, weighted as in our methodology.

PCOS & hormonal suitability65/100
Clinical oversight & labs70/100
Price transparency48/100
Nationwide access84/100
Ongoing support75/100
Cancellation fairness72/100

What we like

  • Standard semaglutide and FORM3 introductory and continuing prices published
  • Separate oral semaglutide $215 and tirzepatide ODT $299 listings
  • Approved-brand membership pathways listed separately from compounds
  • Website acknowledges compounded preparations are not FDA-approved

The caveats

  • Standard, FORM3 and bundle amounts describe different purchases
  • Tirzepatide ODT page contains conflicting oral and injectable wording
  • Brand membership fee should not be mistaken for medication included
  • No dedicated menopause HRT or comprehensive PCOS program established

The full review

FORM by GBY combines weight-management prescriptions with a beauty and wellness catalog. Its current site has more explicit GLP-1 pricing than older versions, including a promoted three-component preparation and separate standard treatment pages. The complication is that those are not all the same product: a homepage bundle, a standard injection and an oral preparation have different prices and descriptions.

For a woman who wants a broad catalog under one account, FORM is relevant to compare. It is less straightforward for someone who wants one unambiguous all-in price or a dedicated menopause clinic. This review evaluates the current public pages and policies.

Which semaglutide and tirzepatide offer?

The standard semaglutide injection page advertises $99 for the first month, then $159 thereafter. The homepage's FORM3 semaglutide, described as a combined preparation with B12 and glycine, is $129 for the first month, then $199 per month. Those are differently described offers, so the higher homepage amount should not automatically be treated as an error or the cheaper product assumed to include the same preparation.

The standard tirzepatide injection page lists $169 for the first month, then $219 thereafter. The homepage separately lists FORM3 tirzepatide at $199 for the first month, then $299 per month. It presents the same introductory and continuing amounts for FORM3 microdose tirzepatide. The separate microdose page shows $199 per month without the same continuing explanation. Confirm the exact selected preparation and renewal charge before choosing from the catalog.

Oral semaglutide is listed at $215 per month, and the tirzepatide ODT page at $299 per month. The latter has conflicting route language: its heading calls it ODT and its benefit copy describes avoiding needles, but a sentence describes an injectable. Ask the clinician to confirm the actual dosage form and product rather than rely on that page wording.

The catalog also includes memberships connected to approved-brand Wegovy and Zepbound routes. A membership charge is not automatically the medicine's cost. Obtain the current program fee, medication expense, supply and renewal details separately. A brand listing does not establish insurance coverage or inclusion at a compounded price.

What do the added ingredients establish?

FORM3 is presented as one compounded prescription combining a GLP-1 ingredient, B12 and glycine. The homepage itself says the added B12 and glycine do not make tirzepatide work better. That is a useful limit on interpreting a triple-component formula as superior weight-loss treatment.

The broader stacks combine products such as tirzepatide, NAD+, glutathione and sermorelin, with separately published bundle amounts. Their presence should not be treated as proof that a woman needs several prescriptions to benefit from weight care. Ask what each component is intended to treat, why it is appropriate for you and whether a simpler alternative meets the same need.

The site acknowledges compounded preparations are not FDA-approved. A familiar active ingredient or references to manufacturer trials do not establish equivalent performance for a particular mixture or oral route. Our compounded versus brand-name guide can help distinguish the formulation and evidence questions.

Clinical process and continuing care

The treatment pages describe a private online intake reviewed by a licensed provider, generally within one to two business days. The clinician decides whether treatment is appropriate and provides next steps for prescribing and fulfillment. Completing the intake does not guarantee a prescription, and the current pages do not establish that every initial assessment includes a scheduled live appointment.

Monthly pharmacy delivery, provider supervision and follow-up are advertised. Ask how follow-up occurs, who handles medication questions and whether a live conversation can be requested. The public offer does not publish a universal response deadline or a routine laboratory schedule for every GLP-1 patient.

The product descriptions refer to a U.S.-licensed compounding pharmacy but do not identify the pharmacy assigned to every order. Before transferring from another clinic, request the actual ingredients, concentration, quantity and instructions. Different products or added ingredients can mean the old label's measuring instructions no longer apply.

FORM's branding comes from GBY Beauty, which explains the presentation and breadth of cosmetic and wellness products. That background is not a substitute for knowing the treating medical practice and pharmacy. Verify those details for the treatment you are considering rather than treat a polished storefront as evidence of a particular clinical experience.

Women's-care scope

The name FORM Era and the catalog's references to vitality do not by themselves establish a menopause hormone service. The reviewed pages do not describe an estradiol-and-progesterone pathway or coordinated management of hot flashes, bleeding changes and weight. If that is your goal, ask which actual women's services are available.

Likewise, the weight-loss offer does not establish specialist PCOS care for fertility plans or menstrual concerns. Weight management may sit alongside care from another clinician without replacing it. Our PCOS guide can help identify which questions require a broader treatment plan.

A woman already receiving HRT should bring the complete medication list and ask whether the FORM prescriber will coordinate with her existing clinician. An extensive peptide catalog does not resolve that communication question. The practical value lies in an appropriate plan and reliable follow-up, rather than the number of possible add-ons.

Cancellation and delivery problems

Treatment FAQs say the subscription can be canceled without a long-term commitment, but the returns policy makes dispensed prescription purchases final. Requests involving a damaged delivered product must be made within three days, and photographs may be required. Approved refunds are limited to one product and may take up to thirty days to appear.

Ask when an order is considered dispensed, how to stop the next renewal and whether the same conditions apply to a multi-product bundle. Canceling future charges and refunding a current prescription are different requests. A flexible subscription label does not guarantee the current shipment can be reversed.

FORM is most useful for a woman willing to compare the exact standard, FORM3 or oral offer and obtain a clear written quote. The main drawbacks are inconsistent route wording on one oral page, overlapping price presentations and limited women's specialty detail. Our provider-selection guide can help compare the resulting clinical and billing arrangement with a simpler program.

Our verdict on FORM (by GBY)

Best for: Women comparing a broad catalog who will distinguish standard treatment from combined preparations and optional bundles.

Listed #85 of 88 providers we reviewed for women — compare with CoreAge Rx. Price transparency is where FORM (by GBY) scores lowest, at 48/100. If that is your sticking point, start with the FORM (by GBY) alternatives, scored on the same six factors.

Related guides

Others in FORM (by GBY)'s score range

The providers scoring closest to FORM (by GBY) on the same six factors. One of those comparisons is written out in full: how FORM (by GBY) and CoreAge Rx compare on the Luna Fit Score, 25 points apart on the Luna Fit Score. Directly below FORM (by GBY) sits RX Bella at #86 with 65/100 — see what women pick instead of RX Bella if that is the band you are shopping in.

See all 88 providers we've reviewed for women — scored on the same rubric, with prices side by side.

Prices and states reflect FORM (by GBY)'s own public pages when we last checked them; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on FORM (by GBY)'s site. Not medical advice; see our disclosure.